DJIA 17,751.39 121.12 0.69%
NASDAQ 5,111.73 22.53 0.44%
S&P 500 2,108.57 15.32 0.73%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

58.54 1.02 (1.77%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MRK $58.54 1.77%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $57.69
Previous Close $57.52
Daily Range $57.64 - $58.82
52-Week Range $52.49 - $63.62
Market Cap $165.4B
P/E Ratio 12.73
Dividend (Yield) $1.80 (3.1%)
Ex-Dividend Date
Dividend Pay Date
09/11/15
10/07/15
Volume 12,860,528
Average Daily Volume 8,871,031
Current FY EPS $3.44

Sector

Healthcare

Industry

Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary Rss Feed

3 Important Questions We Want Answered When Merck Reports Its Q2 Results

Big Pharma Merck is scheduled to report its second-quarter earnings results on July 28. Here are three questions investors are expecting to have answered on that date.

The 4 Stocks That Boosted the DJIA on Wednesday

Trade-Ideas: Merck (MRK) Is Today's "Storm The Castle" Stock

Company News for July 29, 2015 - Corporate Summary

Gilead Beats And Raises: Thinking Through The Future Of Its Business And Its Stock Price

Should Gilead Really Be Rated Underperform?

3 Stocks Driving The Drugs Industry Higher

How To YieldBoost Merck & Co. To 4.9% Using Options

Why Merck is a Top Socially Responsible Dividend Stock (MRK)

Gilead Sciences Beats And Guidance Raise Give It Room To Run Upward

Merck (MRK) Earnings Report: Q2 2015 Conference Call Transcript

See More MRK News...

MRK's Top Competitors

MRK $58.54 (1.77%)
Current stock: MRK
JNJ $99.73 (0.72%)
Current stock: JNJ
NVS $103.69 (0.88%)
Current stock: NVS
RHHBY $36.09 (0.05%)
Current stock: RHHBY